P

Polyneuron Pharmaceuticals AG

4 employees

Polyneuron is a pharmaceutical company, committed to the development of a new drug class for the treatment of autoimmune disorders.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Medical Device
Communities
Medical

Date founded

2014

Funding rounds raised

Total raised

$23M

from 11 investors over 11 rounds

P

Polyneuron Pharmaceuticals AG raised $15M on September 16, 2020

Investors: Sofinnova Partners

P

Polyneuron Pharmaceuticals AG raised $23M on March 28, 2019

Investors: Sofinnova Partners

P

Polyneuron Pharmaceuticals AG raised $3.1M on May 14, 2018

Investors: Zürcher Kantonalbank and EVA - the Basel start-up agency

P

Polyneuron Pharmaceuticals AG raised $129K on January 31, 2018

Investors: BaseLaunch

P

Polyneuron Pharmaceuticals AG raised $3.1M on May 12, 2016

Investors: EVA - the Basel start-up agency and Zürcher Kantonalbank

P

Polyneuron Pharmaceuticals AG raised $401K on February 11, 2016

Investors: Gebert Rüf Stiftung

P

Polyneuron Pharmaceuticals AG raised $139K on May 20, 2015

Investors: Venture Kick

P

Polyneuron Pharmaceuticals AG raised $21K on October 30, 2014

Investors: Venture Kick

P

Polyneuron Pharmaceuticals AG raised $34K on June 3, 2014

Investors: Venture Kick

FAQ